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Induction of apoptosis by the PP1/PP2A inhibitor calyculin Awas inhibited if the CaMKII inhibitor KN-93 was added no later than 10 min after
addition of calyculin A. The physiological relevance andmechanism of CaMKII during apoptosis, however, remains largely unclear. Here we show in
MDCK and gastric parietal cells that normal transregulation of CaMKII terminates the initial burst of autophosphorylation after only 10 min. The
kinetics of CaMKII involved transregulation by PP1, PP2A, PP2B and PKCα. Transregulation of CaMKII resulted in two kinetic phases for
phosphorylation of the autoactivation site at T286/287. During the initial phase, there was a clear peak of phosphorylation that lasted 10 min. This
phase was subsequently followed by a half but constant level of T286/287 phosphorylation. Calyculin A perturbed this transregulation, resulting in a
hyperphosphorylated CaMKII. This effect of CA on the kinetics of CaMKII was observed in vivo as well as in vitro using isolated tubulovesicles.
Calyculin A-induced hyperphosphorylation of CaMKII appears to be at least one mechanism used by cells to trigger apoptosis. Therefore, stringent
limitation of CaMKII autophosphorylation at T286/287 by transregulation and prevention of hyperphosphorylation seems to restrict apoptosis.
© 2007 Elsevier B.V. All rights reserved.Keywords: Adaptation; Apoptosis; Ca2+/calmodulin-dependent protein kinase II (CaMKII); Proteinphosphatases; Protein kinase C (PKC); Signal transduction1. Introduction
The Ca2+/calmodulin-dependent protein kinase II (CaMKII)
transduces elevated Ca2+-signals to phosphorylate a number of
target proteins [1,2]. Activation ofCaMKII decodes the frequency
of Ca2+-spikes [3,4]. Upon Ca2+/calmodulin-dependent activa-
tion, CaMKII undergoes cisphosphorylation at T286/287 of the
autonomy site and T305/306 of the calmodulin binding site [3,4].
Phosphorylation at T286/287 correspondswith activated CaMKII
[1–3]. Several phosphoprotein phosphatases such as PP1, PP2A
and PP2C are known to dephosphorylate at least phospho-T286/
287,which reverses the autonomous state and limits the activity of
CaMKII [5–7].Abbreviations: CA, calyculin A; SA, secretory apical membrane; TV,
tubulovesicles
⁎ Corresponding author. Medizinische Hochschule Hannover, Zentrum
Pharmakologie und Toxikologie, Institut für Pharmakologie OE 5320, Carl-
Neuberg-Str. 1, D-30625 Hannover, Germany.
E-mail address: faehrmann.michael@mh-hannover.de (M. Fährmann).
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2007.10.005Overexpression of CaMKII was shown to increase apoptosis
[8]. Inhibition of CaMKII-counteracting phosphatases PP1 and
PP2A by microcystin also demonstrated that CaMKII is involved
in apoptosis [8]. CaMKII has been implicated in distinct phases of
apoptosis [9]. An early effect (t0.5=9 min) of microcystin was
shrinkage of cytoplasmic and nuclear volume, which could be
reversed by the addition of a CaMKII inhibitor. Microcystin-
dependent dysregulation of CaMKII for 14 min was necessary to
induce the loss of plating ability and the start of budding in 50% of
cells [9]. At an early time-point, microcystin-induced apoptosis
was reversed by specific CaMKII inhibitors, whereas after 15 to
17 min microcystin induced cell death could not be abolished by
inhibition of CaMKII [9]. For both microcystin (0.5 to 2 μM)-
induced effects, membrane budding and the inability to attach to a
substratum, CaMKII activity was necessary for 11.5 to 16.5 min
[9]. After 31 to 40 min of microcystin application, chromatin
hypercondensation could not be abolished by inhibition of
CaMKII [9]. These data suggest that CaMKII should be regulated
in such a way as to prevent its induction of apoptosis but allow for
CaMKII-dependent physiological processes. Epithelial CaMKII,
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associated with exocrine acid secretion [10,11].
Here, we demonstrate that time-dependent transregulation
of CaMKII activity appears to protect cells from apoptosis. Of
general interest, CaMKII is thought to be a target for drug therapy
to prevent CaMKII-dependent apoptosis [12]. Therefore, knowl-
edge of the cellular kinetics of CaMKII may aid the design of an
apoptosis-limiting therapy without affecting other CaMKII-
dependent physiological processes.
2. Materials and methods
2.1. Primary cell culture and preparation of parietal cell membranes
Parietal cells of gastric mucosa were isolated from the stomachs of male
“Wistar” rats by adapted protocols according to [10,13,14]. Preparations of
resting state apical membrane and tubulovesicles (TV) as well as carbachol
(10−4 M)-stimulated apical membrane (SA) from the homogenate of rat gastric
mucosal cells were performed as described [10]. Gastric mucosal cells
containing parietal cells were isolated from PKCα(+/+) or PKCα(−/−) mice,
and cultured for a short time in DMEM F-12 medium. PKCα mutant mice were
generated as previously reported [15]. The enriched membrane fraction of
carbachol (10−4 M)-stimulated cells from mice was regarded as vesicles similar
to SA. Limited amounts of gastric mucosa from PKCα(−/−) mice prevented
preparation of sufficient amounts of TV in parallel.
2.2. Transient transfection and confocal microscopy
MDCK cells have been used for transfection as gastric parietal cells demon-
strate a limited rate of transfection. MDCK-II cells, very generously supplied by
Dr. Beate Sodeik (Institute of Virology, Medizinische Hochschule Hannover,
Germany), were transiently transfected utilizing various forms of CaMKII, each
of which was C-terminally fused to mGFP. This is a mutated form of eGFP at
A207K to abolish aggregation of GFP [16]. All mGFP-CaMKII constructs were
very kindly provided as plasmids by Prof. Paul De Koninck (Université Laval,
Québec, Canada). In the text, mGFP is abbreviated as GFP unless mentioned
otherwise. The following various mutant forms of CaMKII were generated as
described previously: 286Ala [17], 286Asp [18], 1–326 [3] or 315–478 [19].
GFP-CaMKII exhibited phosphotransferase activity [20]. Mutant forms of the
kinase were subcloned into the GFP-CaMKII wild type backbone using a PflMI
restriction insert [20]. Transfections were performed with lipofectamin 2000 in
Optimem medium (both Invitrogen, Carlsbad, CA) with subsequent culture in
DMEM containing high glucose (4.5 mg ml−1). Green fluorescence of live cells
was monitored with a Leica TCS SP2 AOBS confocal LASER scan microscope
(Leica Microsystems, Heidelberg, Germany) at 488 nm excitation to determine
the rate of transfection, which was ≥80%. GFP-CaMKII expression was also
monitoredwith an anti-GFP antibody (sc-8334; Santa Cruz Biotechnology, Santa
Cruz, USA).
2.3. Assays for cytotoxicity
Cytotoxicity of calyculin A (CA) on gastric parietal cells was determined as
apoptosis or necrosis. KN-93 was left on cells for 2 h, which were subsequently
washed with medium. Apoptosis was measured by assessing DNA degradation
utilizing the “Cell Death Detection ELISAplus kit” (Roche, Mannheim, Ger-
many) 24 h after induction. This ELISA is based on the quantitative detection of
mono- and oligonucleosomes in the supernatant of lysed cells using specific
mouse monoclonal antibodies. In parallel, release of lactate dehydrogenase
(LDH) was determined by utilizing the “Cytotoxicity kit” from Roche.
2.4. Determination of CaMKII phosphorylation
SDS-polyacrylamide gel electrophoresis and immunoblot procedures were
performed as previously described [10]. To determine the effect of phosphatases
on CaMKII and since CaMKII uses itself as a substrate (cisphosphorylation), theCaMKII regulatory state was measured as autonomy site-phosphorylated
CaMKII [3] instead of external substrate phosphorylation. As phosphatases may
not only dephosphorylate phosphorylated CaMKII but also CaMKII-phosphor-
ylated substrates, an external substrate was not used. A ternary complex of
CaMKII, phosphatase and a substrate of CaMKII may exhibit various states of
phosphorylation and dephosphorylation. This would be much more difficult to
analyze than the herein analyzed phosphorylation sites of CaMKII. Phosphor-
ylation of the CaMKII autonomy site was detected with a rabbit polyclonal anti-
phospho-T286/287 CaMKII(rat) antibody (Promega, Mannheim, Germany).
There is a strong correlation between the state of autoregulatory phosphorylation
of CaMKII and its phosphotransferase [1–3,10]. Phosphorylation at T305/306
of CaMKII was monitored with a rabbit polyclonal anti-phospho-T305/306
CaMKII(rat) antibody (Chemicon/Millipore, Schwalbach, Germany). To imitate
the cellular Ca2+ influx as local, rapid Ca2+ peaks, Ca2+(0.1 mM) input for full
activation of exocrine CaMKII [21] was constant during in vitro analysis of
CaMKII signalosomes. As a standard reference, CaMKII was purified from hog
gastric mucosa to apparent homogeneity as previously reported [22]. For phar-
macologic or toxic agents, the following final concentrations were used unless
stated otherwise: Carbachol (10−4 M; Sigma, Munich, Germany), calyculin A
(10−8 M; Calbiochem, Nottingham, UK), FK 506 (10−7 M; Alexis, Lausen,
Switzerland), Gö 6976 (10−5 M; Calbiochem), KN-62 (5×10−5 M; Calbiochem),
KN-93 (5×10−5 M; Calbiochem), okadaic acid (10−8 M; Calbiochem), ranit-
idine (10−4 M; Sigma), Ro 31-8220 (10−7 M; Calbiochem) and TPA (10−7 M;
Calbiochem). Autoluminographs were densitometrically analyzed. Data values for
intensities were normalized to control.
2.5. Statistical analysis
Data values are presented as means±standard error of means (S.E.M.). Data
of at least three groups were analyzed for variance (ANOVA) followed by a post
hoc Dunnett test. Pb0.05 was considered to be significant.
3. Results
3.1. Apoptosis is blocked by KN-93 for up to 10 min after
induction by CA
To determine the CaMKII-dependent and -independent phases
of CA-induced apoptosis, MDCK cells were incubated with CA
(10 nM) for various periods of time ranging between 0 and
30 min. After incubation, cells were washed and incubated either
with or without the specific CaMKII-inhibitor KN-93 (50 μM)
(Fig. 1a). To monitor the effect of KN-93 (50 μM) alone, it was
added at the indicated timepoints between 0 and 30 min. There
was a time range between 10 and 11 min in which CA-induced
apoptosis shifted from total sensitivity to insensitivity of KN-93.
(Fig. 1a). Carbachol (0.1 mM)-stimulated gastric parietal cells
were used to compare the effects of CaMKII-inhibitors KN-62
and KN-93 after 10 min or 30 min induction of apoptosis by CA
(10 nM). The CaMKII inhibitors demonstrated a similar ability to
block the CA-induced apoptosis after 10 min, and a failure to
block after 30 min (Fig. 1b). Experiments were performed as for
MDCK cells (Fig. 1a). 5.53±1.7% of untreated parietal cells
exhibited spontaneous apoptosis.
Each GFP-CaMKII vector construct was tested for its effect
on apoptosis (Fig. 1c) and LDH release (Fig. 1d) in MDCK
cells. Transfection of WT GFP-CaMKII or the association do-
main truncated GFP-CaMKII 1–326 increased the apoptotic
rate 1.4±0.2 and 1.7±0.08-fold, respectively (Fig. 1c). The
association domain alone (GFP-CaMKII 315–478) resulted in a
2.9±0.03-fold higher rate of apoptosis. Mutated forms of the
T286 CaMKII autonomy site (GFP-CaMKII T286A or T286D),
Fig. 1. Physiologically regulated CaMKII prevents apoptosis only 10 min. (a) MDCK cells were treated with CA (10 nM) for various time ranges between 0 and
30 min (black points). To demonstrate the effect on CaMKII, KN-93 (50 μM) was added directly in exchange for CA at the given timepoints (0 to 30 min) (white-filled
circles). As controls, cells were left either untreated (black squares) or incubated with KN-93 (50 μM) alone, which was added at the given timepoints (white-filled
squares). KN-93 was left on cells for 2 h. To stimulate CaMKII, ionomycin (1 ng ml−1) was present in each assay. Apoptosis was determined after 24 h of CA treatment
by release of oligo- andmononucleosomes using an ELISA. (b) The same experimental conditions as used forMDCK cells in (a) were examined for gastric parietal cells
except that parietal cells were stimulated with carbachol (CCh, 0.1 mM) instead of ionomycin. Parietal cells were incubated with CA (10 nM) for 10 or 30 min. CA
(“+CCh+CA”) was then exchanged against cell mediumwithout CA, or with KN-62 (50 μM) or KN-93 (50 μM) (“+CCh+KN62/−93+CA”), respectively. As controls,
no carbachol-induction (“w/o CCh”), no toxins (“+CCh”), or only KN-62 or KN-93 (“+CCh+KN62/−93”) was added after 10 or 30 min of CCh-stimulation. ⁎,
significant differences to CCh+ CA alone, Pb0.05 or less. (c) MDCK cells were transiently transfected with various mutated forms of GFP-CaMKII. 24 h after
transfection, apoptosis was determined by mono- and oligonucleosomes. Different forms of CaMKII with a mutated autonomy site (GFP-CaMKII T286A, T286D) as
well as the association domain alone (GFP-CaMKII 315–478) showed significantly increased rates of apoptosis ranging between 2.6 and 3.2. (d) MDCK cells were
transiently transfectedwith variousmutated forms of GFP-CaMKII. 24h after transfection, LDH releasewas determined. LDH release for the same set of transfections as
used for the determination of apoptosis was only minimally increased. ⁎, significant differences in the corresponding control, Pb0.05 or less. (e) Mutant forms of
CaMKII modified cell shape and visible cell–cell contact. MDCK cells were transiently transfected with mutant forms of CaMKII, each of which was fused to GFP, and
monitored in living cells which were not part of a epithelium-like monolayer of cells. (A) Expression of GFP alone without fused CaMKII. (B) Transfected wild type
GFP-CaMKII shows expression over the whole perikaryon as well as the branches (long arrow). Cell–cell contact zones became visible as a result of different levels of
GFP-CaMKII expression (short arrows). (C) GFP-CaMKII 1–326 was localized to the nucleus (arrow) to a much greater extent than the rest of the cell. (D) Expression
of the GFP-tagged C-terminal association domain alone (CaMKII 315–478) led to rounded cell shape and visibly loose cell–cell contact (arrow). (E) Cells
with overexpressed GFP-CaMKII T286A show numerous vacuoles. The body of the cell is rounded up at the nucleus-bearing side of the cell (arrows). (F) Expression of
GFP-CaMKII T286D became punctuate throughout the cytosol and poorly expressed in shortening branches (arrows). Scale bar, 20 μM.
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0.35-time increased rate of apoptosis, respectively. GFP vec-
tor (“mock”) alone did not cause apoptosis (Fig. 1c). Each
LDH assay of various transfected GFP-CaMKII mutant
forms showed only minor increases of LDH release (necrosis)
(Fig. 1d).3.2. Mutant forms of unregulated CaMKII modify cell shape
MDCK cells were transiently transfected with mutant forms of
CaMKII fused to GFP [20] for monitoring by live cell imaging.
GFP expression alone (“GFP mock”) showed a diffuse
distribution of GFP throughout the cell (Fig. 1e-A). Wild type
CaMKII also showed diffuse expression throughout the cell body
as well as in branches (Fig. 1e-B, long arrow). Cell–cell contact
zones became visible by expression of WT GFP-CaMKII (short
arrows, Fig. 1e-B). Expression of GFP-CaMKII 1–326, which
does not contain the association domain, tended to induce a
stretched shape in cell, and was abundant throughout the cell,
although was predominant in the nucleus (arrow) (Fig. 1e-C).
Expression of theGFP-tagged association domain alone (CaMKII
315–478) led to a completely rounded cell shape and a visible loss
in cell–cell contact (arrow) (Fig. 1e-D). GFP-CaMKII T286A
showed a diffuse distribution in cells with numerous vacuoles.
The cell body was rounded up at the nucleus-containing site
(arrows) (Fig. 1e-E). Expression of GFP-CaMKII T286D became
punctuate throughout the cytosol and was poorly expressed in
short branches (Fig. 1e-F, arrows). Cells were remarkably round
shaped (Fig. 1e-F).
3.3. Kinetics of CaMKII phosphorylation
Overexpression of GFP-CaMKII in MDCK cells led to
higher phosphorylation of CaMKII at T286/287 than intrinsic
CaMKII induced by ionomycin (1 ngml−1) (Fig. 2a). There was,
however, a much higher expression of transfected GFP-CaMKII
than of intrinsic CaMKII. The latter could not be detected with
an anti-non-phospho CaMKII antibody (data not shown). GFP-
CaMKII was clearly expressed, as shown by fluorescence in live
cells (Fig. 1d) and by immunoblot staining with an anti-GFP
antibody (Fig. 2a). Each intrinsic or overexpressed CaMKII
showed kinetics of autonomy site phosphorylation with a maxi-
mum after 7 min. Treatment of carbachol (0.1 mM)-stimulated
gastric parietal cells with CA (10 nM) resulted in 4-fold higher
total phosphorylation at T286/287 than the control (Fig. 2b, c). A
preliminary comparison of total phosphorylation at T286/287 of
CaMKII overexpressing cells (“MDCK+WT”) to CA-treated
parietal cells (“PC+CA”) showed 1.6±0.03-fold higher phos-
phorylation in the latter (Fig. 2c).
3.4. Effect of transregulators on the phosphorylation of
TV-signalosome-integrated CaMKII
As a reference to non-signalosome-integrated CaMKII,
purified CaMKII showed a continuous increase of autonomyFig. 2. In vivo kinetics of phosphorylation of CaMKII autonomy site T286/287.
(a) MDCK cells were analyzed for phosphorylation of the autonomy site on
either intrinsic CaMKII or transfected GFP-CaMKII WT after treatment with
ionomycin (1 ng ml−1). (b) Gastric parietal cells (PC) were stimulated with
carbachol (0.1 mM) either in the absence or presence of CA. Phosphorylation of
CaMKII at the autonomy site was analyzed at each timepoint indicated. (c) Total
phosphorylations at T286/287 of CaMKII between 0 and 30 min of experiments
presented in (a) and (b). Data show the mean±S.E.M.⁎, significant differences
to the corresponding control, Pb0.05 or less. n=3–6 separate experiments.
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Fig. 4. Effect of various protein kinase modulators and phosphatase inhibitors on the kinetics of specific phosphorylation of CaMKII T286/287 of SA. Specific
CaMKII phosphorylation utilizing an anti-phospho T286/T287 was normalized to 100% for maximum phosphorylation in each control assay. Kinetics of
phosphorylation were performed with n=3 to 6 different experiments. (a–f ) control without toxins, (a) KN-62, KN-93, (b–f) CA, (b) FK 506, (c) TPA, (d) Gö 6976,
(e) Ro 31-8220. (f) Increased phosphorylation of CaMKII T286/287 present in SA-like plasma membrane of PKCα-deficient mice. Gastric mucosal cells containing
exocrine parietal cells from either wild type (WT) mice or PKCα(−/−) knockout mice (ΔPKCα) were short-term cultured and stimulated with carbachol (0.1 mM) in
the presence of ranitidine (0.1 mM) for 10 min, and optionally CA. For concentrations of toxic agents, see Materials and methods. The standard error of the means is
indicated by error bars.
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[21]). For CaMKII in its TV signalosome, control without any
modulator showed a transient peak of phosphorylation followed
by adaptation to half peak but constant autonomy site phos-
phorylation at T286/287 between 4 and 15 min (Fig. 3a). KN-93
as well as KN-62 strongly inhibited CaMKII phosphorylation
(Fig. 3a). This effect was not compensated or reversed by CA.
CA alone resulted in a strong increase in CaMKII burst phos-
phorylation designated “hyperphosphorylation” with adaptation
on a more than 3-fold higher level than the control (Fig. 3b).Fig. 3. Effect of various protein kinase modulators and phosphatase inhibitors on the
CaMKII phosphorylations utilizing appropriate antibodies (anti-phospho T286/T287
phosphorylation in each control assay. Insets display typical immunoblots of autonom
different experiments. (a–h) Control without toxic agents, (a) KN-62, KN-93, (a+b, d
(f, h) TPA, (c) okadaic acid (OA). For the concentrations of toxins used, see the first p
the anti-CaMKII phospho-T286/287 signal used to assess the kinetics after inductio
phase of phosphorylation of CaMKII. “tp” is the timepoint of peak phosphorylation
adapted phase.Maximal peak phosphorylation of T305/306 was only half
compared to T286/287 when treated with CA (Fig. 3g). Okadaic
acid, which is 100-fold more selective for PP2A than PP1, pro-
longed the duration of the initial, hyperactive phase from 11 min
to 25 min compared to control (Fig. 3c). The PP2B-inhibitor FK
506 had similar but lower effects than CA on CaMKII phos-
phorylation (Fig. 3b). The cPKC inhibitor Gö 6976 shifted the
maximum peak of autonomy site phosphorylation as well as the
adapted phosphorylation to a higher level compared to control
(Fig. 3d). Remarkably, and in contrast to phosphorylation ofkinetics of specific CaMKII-phosphorylations in its TV signalosome. Specific
(a–f) or anti-phospho T305/306 (g, h)) were normalized to 100% for maximum
y site-specific phosphorylated CaMKII. Kinetics were performed with n=3 to 6
−g) calyculin A (CA), (b) FK 506 (FK), (c, d, h) Gö 6976 (Gö), (e) Ro 31-8220,
aragraph of Results. (i) Full-length immunoblot to demonstrate the specificity of
n with Ca2+. (k) Model of kinetics to illustrate the terms “burst” and “adapted”
after Ca2+-induction. “ta” is the turning point that separates the burst from the
Fig. 5. Comparison of the robustness of autonomy site-specific total phosphory-
lation of the CaMKII signalosome in response to kinase or phosphatase modu-
lators. Total autonomy site phosphorylation at T286/287 was compared between
burst phase (time range between induction with free calcium at t0=0, and time tp
of maximal peaking, grey bars, “0-peak”), and adaptation phase (time tp after
peaking to ti =30 min after calcium induction, black bars, “peak - 30”).
Individual timepoints of peaking after induction (tp) are indicated at the upper x-
axis. Total activations between t0 and ti are indicated by white coloured bars
(“0–30”). (a) rat TV, (b) rat SA and mouse (ms) SA-like. All data are sig-
nificantly different from the corresponding control (Pb0.05) excluding (⁎),
where no significance relative to control was observed. For abbreviations, see
legend of Fig. 3.
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tenuated in the presence of Gö 6976 (Fig. 3h). Parallel blocking
of PP1, PP2A and PKCα by CA and Gö 6976 resulted in an
initially hyperphosphorylated CaMKII followed by a dampened
phase to total loss of T286/287 phosphorylation. In the presence
of the cPKC/nPKC inhibitor Ro 31-8220, which should be
specific to PKCα as TV do not carry PKCε [11], an attenuated
kinetics was observed in the presence as well as the absence of
CA (Fig. 3e). The active phorbolester TPA used to activate PKC
induced an attenuated oscillation-like phosphorylation of
CaMKII at T286/287 and T305/306, each of which exhibited
a main peak after 1 min of induction. A second but lower peak
after 7 and 10 min of induction was observed for phosphory-
lation at T286/287 and T305/306, respectively (Fig. 3f, h). The
specificity of the anti-CaMKII phospho-T286/287 is shown in
Fig. 3i. A schematic diagram illustrates the two main phases,
“burst” and “adapted”, of the kinetics of TV-CaMKII phos-
phorylation. “tp” is the time point of maximal phosphorylation
after Ca2+-induction (Fig. 3k).
3.5. Effect of transregulators on the phosphorylation of
SA-signalosome-integrated CaMKII
The apical membrane of unstimulated, resting state cells
exhibited a poor level of CaMKII T286/287 phosphorylation
(Fig. 4a). CaMKII of stimulus-associated membrane (SA)
displayed a basic level of phosphorylation at T286/287. Free
Ca2+ induced a burst of T286/287 activation with a peak after
7 min. Adapted phosphorylation at T286/287 (15 to 30 min) was
similar to that observed at timepoint 0 (Fig. 4a). The presence of
CaMKII inhibitors KN-93 or KN-62 blocked the Ca2+-induced
burst of phosphorylation at T286/287. Moreover, T286/287
phosphorylation of TV-CaMKII (15 to 30 min) was in the same
range as phosphorylation of SA-CaMKII at 0 min (Figs. 3a, 4a).
For SA, inhibition of PP1/PP2A by CA did not increase the
initial burst of specific CaMKII T286/287 phosphorylation but
elevated the adapted level compared to control (Fig. 4b). Com-
bining Gö 6976 with CA strongly increased SA-CaMKII T286/
287 phosphorylation without any clear adaptation (Fig. 4d).
FK 506 did not alter the burst or adapted level of CaMKII
phosphorylation compared to control (Fig. 4b). TPA inhibited
bursting of SA-CaMKII phosphorylation in vitro (Fig. 4c). Gö
6976 increased the burst and adapted level of CaMKII T286/
287 phosphorylation compared to control (Fig. 4d). Ro 31-8220
shifted the peak of maximum T287/287 phosphorylation from 7
to 15 min. Addition of both CA and Ro 31-8220 induced a shift
in peak phosphorylation from 7 to 10 min (Fig. 4e).
For wild type mice, autonomy-site phosphorylation at T286/
287 of CaMKII associated with the SA-like plasma membrane
of carbachol-stimulated cells showed only a moderate increase
in the presence of CA, suggesting a similarity to SA of rats
(Fig. 4a, f). A clear increase in specific phosphorylation at
T286/287 of SA-like associated CaMKII in carbachol-stimu-
lated gastric mucosal cells was observed for PKCα(−/−) mice.
This effect was enhanced in the presence of CA (Fig. 4f). Spe-
cific CaMKII activation at T286/287 at time point tp=15 min
was 1.8-fold higher in PKCα(−/−) mice in the absence, andtp=17.5 min 2.5-fold higher in the presence of CA compared to
wild type mice (Fig. 4f).
Comparing total phosphorylations of CaMKII T286/287 in
the presence of various toxins, the SA signalosome was more
robust than the TV signalosome, especially during the pre-peak
phase (t0 to tp) (Fig. 5a, b). For CaMKII of SA-like membranes
of PKCα-deficient mice, the pre-peak total phosphorylation was
higher than that observed for rat SA. This pre-peak phase of
PKCα-deficient mice was not as robust as rat SA in response to
CA (Fig. 5a, b).
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Epithelial CaMKII is a pivotal regulatory enzyme in exocrine
calcium-dependent signaling [10] and, presumably, in apoptosis
[8,9]. However, it is still unclear by which regulatory processes
and in response to what conditions CaMKII switches from
promoting exocytosis to inducing of apoptosis. As previously
reported, inhibitory toxins of PP1/PP2A need an active CaMKII
to induce apoptosis [8,9]. As PP1 and PP2A counteract the reg-
ulation of CaMKII [6,7,23], inhibition of PP1/PP2A should affect
CaMKII regulation. We recently demonstrated that CaMKII
is integrated in distinct signalosomes comprising at least PP1,
PP2A, PP2B and PKCα [11]. This suggests a more complex
regulation beyond CaMKII autoregulation [1–4]. It was also
recently shown that CaMKII was implicated in different time-
dependent phases of apoptosis [9]. To date, the kinetics of the
regulatory phosphorylations of epithelial CaMKII present in sig-
nalosomes and its effect on apoptosis have not been addressed.
Therefore, the time-dependent phosphorylation of CaMKII pre-
sent in signalosomes and its effect on apoptosis were studied.
It was initially observed that treatment of cells with the
phospho-serinyl/-threoninyl phosphatase inhibitors microcystin-
LR, nodularin or okadaic acid increased apoptosis [8]. CaMKII
was also shown to be involved in specific phases of microcystin-
induced apoptosis in hepatocytes [9]. In the same study, it was
proposed that inhibition of phosphoprotein phosphatases led to a
more active CaMKII compared to cells not treated with phos-
phatase inhibitors. Both the inhibition of phosphoprotein phos-
phatases and the increased activity of CaMKII may lead to an
accumulation of reactive oxygen species (ROS), resulting in in-
creased apoptosis [9].
We confirmed that overexpression of a phosphomimetically
activated CaMKII (CaMKII T286D) increased apoptosis in
MDCK cells. This effect was also shown by Fladmark et al. for
COS cells [8]. We did not, however, find a strong increase in
apoptosis by overexpression of wild type CaMKII as demon-
strated for COS cells [8]. Despite a high transfection rate,
overexpressed WT CaMKII did not reach the level of T286/287
phosphorylation observed for intrinsic CaMKII in non-trans-
fected MDCK cells treated with CA. The lower level of WT
CaMKII activity in transfected cells compared to CA-treated
cells does not seem to be sufficient to trigger apoptosis. In
contrast, we found an apoptosis-inducing effect in response to
either autonomy site non-phosphorylatable CaMKII T286A or
constitutively active T286D as well as with the CaMKII as-
sociation domain alone. We speculate that even overexpression
of phosphorylation adjustable forms of CaMKII (WT, 1–326)
but not regulation-deficient forms of CaMKII (T286D, T286A)
can be integrated in CaMKII-carrying signalosome resulting
in sufficient transregulation and subsequent prevention of
hyperphosphorylation and apoptosis. The rounded shapes of
MDCK cells transfected with regulation-deficient forms of
CaMKII are indicative of an apoptotic phenotype. As these
mutant forms of CaMKII increased LDH leakage only minorly,
CaMKII alone does not seem to be involved in necrosis.
Apoptosis was blocked by inhibition of CaMKII with KN-93 for
up to 10–11 min after induction with CA. This suggests thatCaMKII has to be active for at least 10 to 11 min to commit CA-
induced apoptosis.
The question arises as to how the intracellular activity of
CaMKII is organized to forward physiological tasks but prevent
apoptosis. For gastric parietal cells, it was shown that CaMKII
activity is functionally partitioned in time and space between
cytoplasmic TV and SA [11]. Translocating TV are suggested to
be the main source of active CaMKII at SA [10,11,24]. The
concept of functional partitioning of CaMKII may be important
besides to organize of the exocrine response, to control apoptosis.
Thus, in the present study we here characterized cytoplasmic TV
and SA for the kinetics of regulatory phosphorylation of CaMKII.
We showed that Ca2+-dependent kinetics of CaMKII in its
signalosome exhibited an initial burst of phosphorylation at T286/
287 aswell as T305/306 followed by amedium level of “adapted”
activity. This kind of kinetics was described 25 years ago as an
adaptation process. [25]. Autophosphorylation activity at T286/
287 correlates with phosphotransferase activity of CaMKII at TV
or SA towards the CaMKII-specific, synthetic peptide substrate
autocamtide-II [10,24,26].
PP1 and PP2Awere important transregulators of CaMKII in
the TV signalosome. In the late phase (20 to 30 min) of the
examined kinetics of the TV-signalosome, and by comparing
the effects of the PP1/PP2A inhibitor CA and PP2A-inhibitor
okadaic acid, PP2A lost its effect on CaMKII phosphorylation.
This may be explained by the fact that CaMKII and PP2A
mutually downregulate each other. We propose that a CaMKII–
PP1–PP2A system is predominantly responsible for the adap-
tation of CaMKII activating phosphorylation [27–29]. PP2B
has been detected in the cytoplasm and nucleus, but not the
plasma membrane, of gastric parietal cells [30]. PP2B is not
known to dephosphorylate CaMKII directly [6], yet it supports
the attenuation of cytoplasmic CaMKII activity presumably by
upregulating the activity of PP1 indirectly by dephosphorylat-
ing its inhibitor phospho-I-1 [27].
A direct attenuator of CaMKII activity, presumably by direct
phosphorylation, is PKCα. This was shown on the biochemical
level with purified CaMKII and PKCα in vitro as well as on
the cell physiological level utilizing specific PKC inhibitors
[26,31,32]. CaMKII, from either neuronal tissue or gastric
mucosa, was demonstrated to be directly phosphorylated by
PKCα [26,32]. In the case of gastric mucosal CaMKII, it was
also shown that PKC-dependent phosphorylation of CaMKII
reduced the phosphotransferase activity of CaMKII [32]. We
observed that in gastric parietal cells each PKC-inhibitor, Gö
6976 or Ro 31-8220, positively affected the in vivo activity of
CaMKII. These inhibitors became specific as, in the chosen cell
system, PKCα was the only member of the cPKC subfamily
found to be abundant [26]. Here we show that inhibition of
PKCα activity diminished phosphorylation at the calmodulin-
binding site, suggesting that PKCα partially contributes to
phosphorylation at T305/306 of CaMKII and thus strengthening
Ca2+/calmodulin-independence of activated CaMKII [33].
PKCα-dependent attenuation of CaMKII phosphorylation at
T286/287 was not observed to be additive for the suppressive
activity of PP1 and PP2A. It was demonstrated elsewhere that
both PP1 and PP2A dephosphorylate cisphosphorylation but
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regulatory subunit is transphosphorylated by PKCα, indicating
a bidirectional, mutual transregulation of PP2A and PKCα [34].
These interactions help to explain why simultaneous blocking
of PP1/PP2A and PKCα did not result in a synergistically
induced hyperactivity of CaMKII present in TV.
SA contains predominantly autoactivated, autonomous
CaMKII, which explains the already “adapted” medium level
of activity [10]. Despite this fact, calcium is able to induce a
short-term burst of phosphorylation in SA-CaMKII. The early
phase before the peak of maximum phosphorylation at T286/287
of SA-CaMKII was much more robust towards any toxic per-
turbation besides KN-93, KN-62 or TPA, than TV-CaMKII. We
assume that the robustness of SA-CaMKII phosphorylation
is closely associated with the activity of PKCα, which may
enhance the activity of PP1/PP2A. In essence, Ca2+-dependent
activation of SA-CaMKII activity for only effective if the
activities of PKCα and PP1/PP2Awere simultaneously blocked.
This observation was confirmed for in vitro studies of SA-like
plasma membranes of PKCα-deficient mice, suggesting the
interdependent role of both PP1 and PP2A as well as PKCα
during adaptation of CaMKII activity.
The kinetics of CaMKII phosphorylation in signalosomes can
be divided into two phases (Fig. 3k), each of which seems to have
its own function. The initial burst of CaMKII phosphorylation
and, therefore, its activation has been observed to be stringently
time-limited. It did not last more than 10minwith amaximal peak
after 7 min of induction. A short-term peak of activity may be
necessary to trigger Ca2+-dependent downstream physiological
events other than apoptosis. As recently reported, application of
microcystin (0.5 to 2 μM) and CaMKII activity are both required
for at least 11.5 to 16.5 min to induce detachment of cells and
launch zeiosis as necessary steps leading to apoptosis [9]. There-
fore, the observed initial peak of CaMKII phosphorylation, which
lasted ≤10 min, did not appear to be sufficient to induce apo-
ptosis. In the presence of PP1/PP2A inhibitor toxins, signalo-
some-associated CaMKII exhibited hyperphosphorylation for
≥10 min, which seems to be enough to trigger apoptosis [9].
After 15 to 20 min, microcystin-induced apoptosis became
independent from CaMKII [9].
To assess the role of partitioning of CaMKII activity [11], we
found a strong similarity between the kinetics of CaMKII phos-
phorylation in vivo compared to the kinetics of TV in vitro.
Similarities were less obvious for the kinetics of CaMKII phos-
phorylation in vivo compared to SA in vitro. Thus, CaMKII of
cytoplasmic TVappears to be more involved in the regulation of
apoptosis than SA-CaMKII. CaMKII signalosomes of TV ap-
pear to represent a precisely tuned system designed to induce
apoptosis in response to perturbed transregulation of CaMKII.
In summary, transregulation of CaMKII phosphorylations at
T286/T287 and T305/306 of cytoplasmic TV signalosomes by
PP1, PP2A, PP2B and PKCα stringently enables only short-term
(≤10 min) burst activation of CaMKII regulatory sites, which is
not sufficient to trigger apoptosis. Hyperphosphorylation for
N10 min induced by PP1/PP2A-inhibitors such as CA or
overexpression of constitutively active CaMKII leads increased
apoptosis. Hence, transregulation of CaMKII admits a workingCaMKII, which only supports apoptosis during perturbations of
upstream signal transduction in its transregulators.
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